From: The soft computing-based approach to investigate allergic diseases: a systematic review
Authors | Application | Subjects | Description | Input features | SC model | Findings |
---|---|---|---|---|---|---|
Prosperi et al. [6] | To predict asthma severity | 383 children with asthma (age 6–18 years) | Use of unsupervised statistical learning techniques, such as exploratory factor analysis (EFA), hierarchical clustering (HC) to identify asthma phenotypes | Lung function, inflammatory and allergy markers, family history, environmental exposures, body mass index, age of asthma onset and medications | BN | Significant recognition of asthma severity |
Farion et al. [12] | To predict asthma exacerbation | 322 Phase 1: 240 children (age 1–17 years) Phase 2: 82 children (age 1–17 years) | Phase 1: selection of the most accurate machine learning model with WEKA tool Phase 2: comparison of performance of BN with PRAM score and Physicians | 42 attributes corresponding to the patient’s history, current asthma exacerbation, primary assessment and a selected secondary assessment | BN | Phase 1: Accuracy = 68% Phase 2: Accuracy = 70.7% |
Finkelstein et al. [13] | To predict asthma exacerbation | 26 adult asthmatic patients | Use of a modern tele-monitoring system at home | Daily self-reports | SVM | Accuracy = 80% Sensitivity = 84% Specificity = 80% |
Sanders et al. [10] | To predict asthma exacerbation | 4023 patients (age 2–18 years) | Use of a SC model to identify patients eligible for asthma care guidelines | Past diagnoses, allergies, family history, medications, social history and vital signs (temperature, respiratory rate, and oxygen saturation) | BN | Accuracy = 96% Sensitivity = 90% Specificity = 88.3% |
Dexheimer et al. [11] | Same of Sanders et al. [10] | 4023 patients (age 2–18 years) | Comparison of machine learning models to best identify patients eligible for an asthma care guideline | Same of Sanders et al. [10] | ANN,BN, Gaussian processes (GP) | BN accuracy = 96% GP accuracy = 95.6% ANN accuracy = 94% |
Pifferi et al. [20] | To classify asthma control levels | 77 patients (age 7.5–17 years) | Assessment of spirometry and fractional exhaled nitric oxide (FeNO) measurements to classify asthma control according to GINA guidelines | 1st model: values of spirometry; 2nd model: values of FeNO; 3rd model: values of spirometry and FeNO | ANN | 3rd model achieved best performances of classification Accuracy = 86.4% |
Pifferi et al. [17] | To classify asthmatic vs control | 123 90 asthmatic children (age 9–16 years) and 33 controls (age 12–13 years), | Pattern recognition analysis of the exhaled breath temperature curve | The rate of temperature increase and the mean plateau value | ANN | Accuracy = 5% Sensitivity = 77.2% Specificity = 99% |
Jaing et al. [21] | To classify how children manage their asthma | 305 children (age 5–14 years) | Each participant was given 10 asthma-based problems and asked to manage them | Each management decision and its order | ANN | Significant classification of five major classes representing different approaches to solving an acute asthma case |
Kharroubi et al. [24] | To classify health state of patient with asthma | 307 subjects | Estimation of a preference-based index for asthma (five-dimensional asthma quality of life utility index) | 99 features about health statuses | BN | BN model is more appropriate than conventionally used parametric random-effects model |
Hirsch et al. [4] | To classify asthmatic vs control | 6825 adults (age ≥ 16) | Respiratory questionnaires were analyzed by experts and compared with results provided by neural network | 12 answers provided by the respiratory questionnaire (wheezing, chest tightness, shortness of breath, night cough), family history of asthma and associated conditions of hay fever or eczema | ANN | Accuracy = 74% |
Chatzimichail et al. [19] | To classify asthmatic vs control | 112 children (age 7–14 years) | Three step analysis:1-feature selection with Principal Component Analysis, 2-pattern classification, 3-performance evaluation | 46 prognostic factors including data on asthma, allergic diseases, and lifestyle factors | SVM | Accuracy = 95.54% Sensitivity = 95.45% Specificity = 95.59% |
Goulart et al. [32] | To classify allergic conjunctivitis vs control | 102 48 with allergic conjunctivitis and 54 controls (age 3–14 years) | Allergic conjunctivitis questionnaires were analyzed by experts and compared with results provided by neural network | 7 items selected from a questionnaire of 15 answers | ANN | Accuracy = 100% |
Takahashi et al. [33] | To classify atopic dermatitis vs control | 4610 answers, 2714 infants (12 months old) and 1896 children (2 years old) | To analyze the predictive accuracy of the predictive model for effect of atopic dermatitis in infancy, from the data of the epidemiological survey | Family history (father, mother, siblings, grand-father, grand-mother), food restriction, food allergy, age, food restriction of mother, egg introduced time, cow’s milk introduced time | ANN | Accuracy = 96.4% Sensitivity = 88.6% Specificity = 99.5% |
Christopher et al. [31] | To classify allergic rhinitis vs control | 872 patients of all age groups | Allergic rhinitis reports of intradermal skin tests were analyzed by experts and compared with results provided by neural network | Patient’s history and 40 clinically relevant allergens | ANN | Accuracy = 88.31% Sensitivity = 88.3% Specificity = 88.2% |
De Matas et al. [23] | To predict the clinical effect of salbutamol | 23 12 healthy volunteers and 11 mild asthmatics | In vivo and in vitro data of human subjects were analyzed using SC modeling | Demographic data and urinary levels of salbutamol and metabolite | ANN | Accuracy = 83.5% |
De Matas et al. [22] | To predict the clinical effect of salbutamol | 18 mild-moderate asthmatic patients | SC modeling to predict the bronchodilator response at 10 (T10) and 20 (T20) min after receiving each of the 4 doses for each of the 3 different particle sizes | Aerodynamic particle size (APS), body surface area (BSA), age, pre-treatment forced expiratory volume in one-second (FEV1), forced vital capacity, cumulative emitted drug dose and bronchodilator reversibility | ANN | Accuracy = 88% |
Gandhi et al. [25] | To predict hypersensitivity reaction | 2458 reports concerning thrombotic events selected from AERS (adverse event reporting system) database | Retrospective analysis focused on thrombotic events associated with C1 esterase inhibitor products | Adverse events; demographic and administrative information; drug/biologic information; report sources; patient outcomes; drug therapy start and end dates; indications for use/diagnosis | BN | Potential signals of C1 esterase inhibitor product—associated thrombotic events among patients with hereditary angioedema were identified |
Naranjo et al. [28] | To predict the posterior probability of a drug (BARDI tool) | 51 patients | BARDI tool, calculates the posterior probability of a drug being the cause based on epidemiologic and case data | Reactions after receiving aromatic anticonvulsants | BN | Accuracy = 93% Sensitivity = 94% Specificity = 50% |
Lanctot et al. [29] | To predict the posterior probability of a drug (BARDI tool) | 27 cases of skin reactions | BARDI, combined with the LTA, a biochemical test that determines the percent of cell death because of toxic metabolites of a drug | Skin reactions associated with sulfonamide therapy | BN | Accuracy = 96% Sensitivity = 79% Specificity = 38% |
Lanctot et al. [30] | To predict the posterior probability of a drug (BARDI tool) | 106 challenging cases | BARDI, compared with the Adverse Drug Reaction Probability Scale (APS) | Drug- and nondrug-induced adverse events | BN | BN model discriminate better than ADR drug from nondrug-induced cases. |
Kadoyama et al. [26] | To predict hypersensitivity reaction caused by anticancer agents | 1,644,220 reported cases from 2004 to 2009 (AERS database) | SC model to detect important pattern related to anticancer agents-associated adverse events | Adverse events; demographic and administrative information; drug/biologic information; report sources; patient outcomes; drug therapy start and end dates; indications for use/diagnosis | BN | Potential signals were detected for paclitaxel-associated mild, severe, and lethal hypersensitivity reactions, and docetaxel-associated lethal reactions |
Sakaeda et al. [27] | To predict hypersensitivity reactions caused by platinum agents | 1,644,220 reported cases from 2004 to 2009 (AERS database) | The BN analysis aims to search for previously unknown patterns and automatically detect important signals, i.e., platinum agent-associat d adverse events, from such a large database | Adverse events; demographic and administrative information; drug/biologic information; report sources; patient outcomes; drug therapy start and end dates | BN | Significant association between the platinum agent-and mild, severe, and lethal hypersensitivity reactions |
Lurie et al. [16] | To classify asthma severity | 113 patients (age 42.9 ± 16.3 years) | Implementation of a fuzzy model able to combine patients’ and doctors’ asthma perceptions | Doctor assessment, variables self-assessed by patients (dyspnea, perceived treatment efficacy, asthma-related quality of life questionnaire (AQLQ)), patients’ sociodemographic characteristics, and asthma characteristics | FL | Accuracy = 73% |
Zolnoori et al. [8] | To classify asthma control level | 42 asthmatic patients | Implementation of a fuzzy model able to estimate the level of asthma control and help physicians to manage their patients more effectively | Respiratory symptom severity, bronchial obstruction, asthma instability, current treatment and quality of life | FL | Accuracy = 100% |
Zolnoori et al. [14] | To classify asthma exacerbation | 25 patients | Implementation of a fuzzy model able to estimate the level of asthma exacerbation and help physicians to manage their patients more effectively | Status of breathless, status of wheeze, status of alertness, status of respiratory rate, status of talk, status of pulse/min heart rate, value of PEF after initial bronchodilator, value of paCO2, value of SaO2% | FL | Accuracy = 100% |
Zolnoori et al. [15] | To classify asthma severity | 28 patients | Implementation of a fuzzy model able to estimate the four categories of asthma severity and help physicians to manage their patients more effectively | Bronchial obstruction, response to drug, skin prick test, severity of respiratory symptoms, instability of asthma, IgE value, quality of life | FL | Accuracy = 100% |
Zolnoori et al. [18] | To classify asthmatic vs control | 278 139 asthmatic patients and 139 non-asthmatic patients (age range 6–18) | Implementation of a fuzzy model to help physicians to manage their patients more effectively | Medical history, environmental factors, allergic rhinitis, genetic factors, consequences of asthma on lung tissues, response to laboratory tests and response to short-term medicine | FL | Sensitivity = 88% Specificity = 100% |